BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8851771)

  • 21. Achondroplasia in Sweden caused by the G1138A mutation in FGFR3.
    Alderborn A; Anvret M; Gustavson KH; Hagenäs L; Wadelius C
    Acta Paediatr; 1996 Dec; 85(12):1506-7. PubMed ID: 9001669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of the FGFR3 gene in Japanese patients with achondroplasia and hypochondroplasia.
    Katsumata N; Mikami S; Nagashima-Miyokawa A; Nimura A; Sato N; Horikawa R; Tanae A; Tanaka T
    Endocr J; 2000 Mar; 47 Suppl():S121-4. PubMed ID: 10890199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Achondroplasia is defined by recurrent G380R mutations of FGFR3.
    Bellus GA; Hefferon TW; Ortiz de Luna RI; Hecht JT; Horton WA; Machado M; Kaitila I; McIntosh I; Francomano CA
    Am J Hum Genet; 1995 Feb; 56(2):368-73. PubMed ID: 7847369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FGFR3 gene mutation (Gly380Arg) with achondroplasia and i(21q) Down syndrome: phenotype-genotype correlation.
    Chen H; Mu X; Sonoda T; Kim KC; Dailey K; Martinez J; Tuck-Muller C; Wertelecki W
    South Med J; 2000 Jun; 93(6):622-4. PubMed ID: 10881785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia.
    Shiang R; Thompson LM; Zhu YZ; Church DM; Fielder TJ; Bocian M; Winokur ST; Wasmuth JJ
    Cell; 1994 Jul; 78(2):335-42. PubMed ID: 7913883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans.
    Meyers GA; Orlow SJ; Munro IR; Przylepa KA; Jabs EW
    Nat Genet; 1995 Dec; 11(4):462-4. PubMed ID: 7493034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Association of achondroplasia to a mutation in the transmembrane domain of fibroblastic growth factor receptor 3 (FGFR3)].
    Rousseau F; Bonaventure J; Le Merrer M; Munnich A
    Ann Endocrinol (Paris); 1996; 57(3):151-2. PubMed ID: 8949407
    [No Abstract]   [Full Text] [Related]  

  • 28. A common FGFR3 gene mutation is present in achondroplasia but not in hypochondroplasia.
    Stoilov I; Kilpatrick MW; Tsipouras P
    Am J Med Genet; 1995 Jan; 55(1):127-33. PubMed ID: 7702086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotyping of the G1138A mutation of the FGFR3 gene in patients with achondroplasia using high-resolution melting analysis.
    Hung CC; Lee CN; Chang CH; Jong YJ; Chen CP; Hsieh WS; Su YN; Lin WL
    Clin Biochem; 2008 Feb; 41(3):162-6. PubMed ID: 18199430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential activation of cysteine-substitution mutants of fibroblast growth factor receptor 3 is determined by cysteine localization.
    Adar R; Monsonego-Ornan E; David P; Yayon A
    J Bone Miner Res; 2002 May; 17(5):860-8. PubMed ID: 12009017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Achondroplasia in diverse Jewish and Arab populations in Israel: clinical and molecular characterization.
    Falik-Zaccai TC; Shachak E; Abeliovitch D; Lerer I; Shefer R; Carmi R; Ries L; Friedman M; Shohat M; Borochowitz Z
    Isr Med Assoc J; 2000 Aug; 2(8):601-4. PubMed ID: 10979354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3.
    Colvin JS; Bohne BA; Harding GW; McEwen DG; Ornitz DM
    Nat Genet; 1996 Apr; 12(4):390-7. PubMed ID: 8630492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fibroblast growth factor receptor and achondroplasia].
    Tanaka H
    Clin Calcium; 2006 Nov; 16(11):1888-93. PubMed ID: 17079857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A simple and rapid quantitative method of detection of the common achondroplasia mutation: analysis in mismatch repair deficient cells.
    Grewal RP
    Genetika; 2005 Aug; 41(8):1137-41. PubMed ID: 16161636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PCR-induced sequence alterations hamper the typing of prehistoric bone samples for diagnostic achondroplasia mutations.
    Pusch CM; Broghammer M; Nicholson GJ; Nerlich AG; Zink A; Kennerknecht I; Bachmann L; Blin N
    Mol Biol Evol; 2004 Nov; 21(11):2005-11. PubMed ID: 15254256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FGFR3 gene mutations in transmembrane domain in Chinese achondroplasia and hypochondroplasia patients.
    Yan-Ling G; Ji-Hong N; Guo-Qiang L; Wei W; De-Fen W
    Horm Res; 1998; 49 Suppl 1():57. PubMed ID: 9554479
    [No Abstract]   [Full Text] [Related]  

  • 37. Insulin-like growth factor-1 rescues the mutated FGF receptor 3 (G380R) expressing ATDC5 cells from apoptosis through phosphatidylinositol 3-kinase and MAPK.
    Koike M; Yamanaka Y; Inoue M; Tanaka H; Nishimura R; Seino Y
    J Bone Miner Res; 2003 Nov; 18(11):2043-51. PubMed ID: 14606518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An uncommon G375C substitution in a newborn with achondroplasia.
    Addor MC; Gudinchet F; Truttmann A; Schorderet DF
    Genet Couns; 2000; 11(2):169-74. PubMed ID: 10893668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The achondroplasia mutation does not alter the dimerization energetics of the fibroblast growth factor receptor 3 transmembrane domain.
    You M; Li E; Hristova K
    Biochemistry; 2006 May; 45(17):5551-6. PubMed ID: 16634636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mutations of the fibroblast growth factor receptor 3 gene in achondroplasia].
    Zhao P; Ma H; Wang Y; Mi Z; Wu Y; Jiang M; Gao H; Li Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Feb; 16(1):16-8. PubMed ID: 9949234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.